Europe Diabetes Care Devices Market Size, Share & Trends Analysis Report By Product (BGM Devices, Insulin Delivery Devices), By Distribution Channel, By End-use, By Country, And Segment Forecast, 2024

Description

Europe Diabetes Care Devices Market Growth & Trends:

The Europe diabetes care devices market size is expected to reach USD 15.11 billion by 2030, registering a CAGR of 7.0% during the forecast period, according to a new report by Grand View Research, Inc. The size of the market is justified by the contribution from developed European economies such as Germany, U.K., France, and Italy. The prevalence of diabetes is rising amongst all ages in the European countries, mainly due to the unhealthy lifestyle, obesity, overweight, and physical inactivity. According to the International Diabetes Federation (IDF), around 66.0 million people in Europe are suffering from diabetes and this number is expected to increase to around 81.0 million by 2045. Thus, rising diabetes population base in this region is anticipated to be a major driver for the Europe diabetes devices market.

Additionally, the region is expected to witness high growth rate during the forecast period due to the continuous efforts towards diabetes control by the government and healthcare organizations such as the IDF. These organizations provide required expertise and support diabetes awareness campaigns through a network of stakeholders and partners. Also, increasing health care funding in the region is anticipated to propel the market's growth.

Moreover, rising geriatric population is also anticipated to propel the market growth over the forecast period. In 2018, nearly one fifth of the Europe's population was over 65 years age which is further fueling the diabetes device market. According to the United Nation report on World Population Aging, older population in Europe is projected to constitute 35.0% of total population by 2050. Furthermore, leading manufacturers are focusing on technological innovations and advanced product development to gain remarkable share in the market.

Europe Diabetes Care Devices Market Report Highlights:

Germany diabetes care device market is expected to grow rapidly during the forecast period, owing to favorable reimbursement policies, local presence of key market players, and supportive government initiatives.
Blood glucose monitoring (BGM) devices are expected to register significant growth over the forecast period, registering a CAGR of 6.5% over the forecast period.
In 2023, Hospital pharmacies dominated the market and accounted for a share of 54.1%.
Insulin pumps segment is expected to grow during the forecast period. The segment is primarily driven by its advantage such as need of fewer injections to deliver insulin.

Product Code: GVR-3-68038-967-8

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Europe Diabetes Care Devices Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Europe Diabetes Care Devices Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Europe Diabetes Care Devices Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Europe Diabetes Care Devices Market: Product Movement Analysis, USD Million, 2023 & 2030
4.3. Blood Glucose Monitoring Devices
- 4.3.1. Blood Glucose Monitoring Devices Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.2. Self-Monitoring Devices
  - 4.3.2.1. Self-Monitoring Devices Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.2. Blood Glucose Meter
    - 4.3.2.2.1. Blood Glucose Monitoring Devices Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.3. Testing Strips
    - 4.3.2.3.1. Testing Strips Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.4. Lancets
    - 4.3.2.4.1. Lancets Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.3. Continuous Glucose Monitoring Devices
  - 4.3.3.1. Continuous Glucose Monitoring Devices Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.3.3.2. Sensors
    - 4.3.3.2.1. Sensors Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.3.3.3. Transmitter
    - 4.3.3.3.1. Transmitter Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.3.3.4. Receiver
    - 4.3.3.4.1. Receiver Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Insulin Delivery Devices
- 4.4.1. Insulin Delivery Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2. Pens
  - 4.4.2.1. Pens Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3. Pumps
  - 4.4.3.1. Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.4. Syringes
  - 4.4.4.1. Syringes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.5. Jet Injector
  - 4.4.5.1. Jet Injector Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Europe Diabetes Care Devices Market: Distribution Channel Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Europe Diabetes Care Devices Market: Distribution Channel Movement Analysis, USD Million, 2023 & 2030
5.3. Hospital Pharmacies
- 5.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Retail Pharmacies
- 5.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Diabetes Clinics/Centers
- 5.5.1. Diabetes Clinics/Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Online Pharmacies
- 5.6.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
- 5.7.1. Others Distribution Channel Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Europe Diabetes Care Devices Market: End Use Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Europe Diabetes Care Devices Market: End Use Movement Analysis, USD Million, 2023 & 2030
6.3. Hospitals
- 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Diagnostic Centers
- 6.4.1. Diagnostics Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Homecare
- 6.5.1. Homecare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Europe Diabetes Care Devices Market: Country Estimates & Trend Analysis

7.1. Europe Diabetes Care Devices Market Share, By Countries, 2023 & 2030, USD Million
7.2. UK
- 7.2.1. UK Europe Diabetes Care Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Germany
- 7.3.1. Germany Europe Diabetes Care Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. France
- 7.4.1. France Europe Diabetes Care Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Italy
- 7.5.1. Italy Europe Diabetes Care Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Spain
- 7.6.1. Spain Europe Diabetes Care Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Denmark
- 7.7.1. Denmark Europe Diabetes Care Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Sweden
- 7.8.1. Sweden Europe Diabetes Care Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9. Norway
- 7.9.1. Norway Europe Diabetes Care Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
- 8.4.1. Medtronic plc
  - 8.4.1.1. Participant's Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Recent Developments/Strategic Initiatives
- 8.4.2. Abbott Laboratories
  - 8.4.2.1. Participant's Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Recent Developments/Strategic Initiatives
- 8.4.3. F. Hoffmann-La Roche Ltd.
  - 8.4.3.1. Participant's Overview
  - 8.4.3.2. Financial Performance
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Recent Developments/Strategic Initiatives
- 8.4.4. Bayer AG
  - 8.4.4.1. Participant's Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Recent Developments/Strategic Initiatives
- 8.4.5. LifeScan IP Holdings, LLC
  - 8.4.5.1. Participant's Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Recent Developments/Strategic Initiatives
- 8.4.6. B. Braun Melsungen AG
  - 8.4.6.1. Participant's Overview
  - 8.4.6.2. Financial Performance
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Recent Developments/Strategic Initiatives
- 8.4.7. Dexcom, Inc.
  - 8.4.7.1. Participant's Overview
  - 8.4.7.2. Financial Performance
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Recent Developments/Strategic Initiatives
- 8.4.8. Insulet Corporation
  - 8.4.8.1. Participant's Overview
  - 8.4.8.2. Financial Performance
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Recent Developments/Strategic Initiatives
- 8.4.9. Companion Medical, Inc.
  - 8.4.9.1. Participant's Overview
  - 8.4.9.2. Financial Performance
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Recent Developments/Strategic Initiatives
- 8.4.10. Sanofi S.A.
  - 8.4.10.1. Participant's Overview
  - 8.4.10.2. Financial Performance
  - 8.4.10.3. Product Benchmarking
  - 8.4.10.4. Recent Developments/Strategic Initiatives
- 8.4.11. Valeritas Holdings, Inc.
  - 8.4.11.1. Participant's Overview
  - 8.4.11.2. Financial Performance
  - 8.4.11.3. Product Benchmarking
  - 8.4.11.4. Recent Developments/Strategic Initiatives
- 8.4.12. Novo Nordisk A/S
  - 8.4.12.1. Participant's Overview
  - 8.4.12.2. Financial Performance
  - 8.4.12.3. Product Benchmarking
  - 8.4.12.4. Recent Developments/Strategic Initiatives
- 8.4.13. Arkray, Inc.
  - 8.4.13.1. Participant's Overview
  - 8.4.13.2. Financial Performance
  - 8.4.13.3. Product Benchmarking
  - 8.4.13.4. Recent Developments/Strategic Initiatives

Europe Diabetes Care Devices Market Size, Share & Trends Analysis Report By Product (BGM Devices, Insulin Delivery Devices), By Distribution Channel, By End-use, By Country, And Segment Forecast, 2024 - 2030